Board on Health Sciences Policy

Meeting

Community Listening Session to Inform the Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment: A Workshop

October 26, 2023

6:00 PM - 7:00 PM (ET)

Past

About

The National Academies of Science, Engineering, and Medicine (National Academies) hosted a virtual workshop on November 6-7, 2023, on the Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment. To inform this work, the planning committee planned a community listening session to obtain feedback to ensure the workshop is aligned with the community’s needs and to ensure that the community’s experiences and perspectives are understood and considered. This listening session was intended for the general population and all of those from the affected areas.

Organizing Project

Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment: A Workshop

Contact

Matthew Masiello

(202) 334-2133
mmasiello@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Workshop 4: Public-Private Partnerships for Distribution of Medical Countermeasures

October 26, 2023

12:00 PM - 2:00 PM (ET)

Past

Materials

About

Readying medical countermeasures for timely distribution and delivery to points of dispensing in a public health emergency is a challenge. The focus of this workshop is to explore the use of public-private partnerships to ensure equitable and efficient distribution of medical countermeasures to affected populations.

Specifically, this workshop will:

Share examples of how public-private partnerships can be coordinated to develop and implement medical countermeasure distribution strategies and ensure resources, including personnel, equipment, technology, and physical space, are in place to manage, transport, and track medical countermeasures.
Share examples of how public-private partnerships can increase access to medical countermeasures from supply sources, distribute medical countermeasures equitably, monitor inventories and distribution, and recover unused medical countermeasures.
Understand the barriers to and facilitators of public-private partnerships for distribution of medical countermeasures.
Identify how policies, systems, and perceptions need to shift to enable public-private partnerships for distribution of medical countermeasures.

Background

Many of the lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). Less focused on were those public-private partnerships that enabled the successful implementation (distribution, dispensing, monitoring, uptake, and utilization) of medical countermeasures (MCMs), also known as the “last-mile”.

A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a series of virtual public workshops to examine lessons learned and future opportunities for public-private partnerships through novel distribution and dispensing models to facilitate delivery, uptake. and utilization of medical countermeasures (MCM) to the public during a public health emergency. This workshop will be hosted by the Forum on Medical and Public Health Preparedness for Disasters and Emergencies.

The five-part workshop series will build on lessons learned from various public-private partnerships models deployed during the “last-mile” of the COVID-19 response and other recent health emergencies, such as retail pharmacies as points of diagnosis and dispensing of MCMs, and discuss potential paths forward for public-private partnerships to facilitate successful implementation of MCMs to the public during a health emergency. For this workshop series, MCMs are medicines and medical supplies that may be used to diagnose, prevent, or treat disease during a public health emergency.[1] Additionally, public-private partnerships refer to cross-sector collaborations between government, private for-profit, and non-profit entities.

Other workshops in the series include:

Workshop 1: Public-Private Partnerships for Data-Informed Decision-Making to Distribute, Dispense, and Administer Medical Countermeasures – Tuesday, October 3, 2023, 12:00 pm – 2:00 pm ET
Workshop 2: Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures – Thursday, October 12, 2023, 12:00 pm – 2:00 pm ET
Workshop 3: Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures – Tuesday, October 17, 2023, 12:00 pm – 2:00 pm ET
Workshop 4: Public-Private Partnerships for Distribution of Medical Countermeasures – Thursday, October 26, 2023, 12:00 pm – 2:00 pm ET
Workshop 5: Future Opportunities: Levers and Systems for Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures – Thursday, November 2, 2023, 12:00 pm – 2:00 pm ET

For additional information on the workshop series, please visit our project page.

Workshop Planning Committee

Ali S. Khan, M.D., M.P.H. (Chair), University of Nebraska Medical Center

Brooke Courtney, J.D., M.P.H., U.S. Food and Drug Administration

Nicole Errett, Ph.D., M.S.P.H., University of Washington

John Hick, M.D., Hennepin Healthcare

Christine Kosmos, M.S., Centers for Disease Control and Prevention

Nicolette Louissaint, Ph.D., Healthcare Distribution Alliance

Jennifer Martin, Pharm.D., Department of Veterans Affairs

Suzet McKinney, Dr.P.H., M.P.H., Sterling Bay

Anita Patel, Pharm.D., Walgreens

Sara Roszak, M.A., M.P.H., Dr.P.H., National Association of Chain Drug Stores

Monica Schoch-Spana, Ph.D., Johns Hopkins Center for Health Security

Stephen Thomas, Ph.D., University of Maryland

[1] CDC (U.S. Centers for Disease Control and Prevention). Medical Countermeasures. https://www.cdc.gov/orr/readiness/mcm2-508.html (Accessed September 5, 2023)

Organizing Project

Medical Countermeasures - Expanding Delivery and Increasing Uptake Through Public-Private Partnerships: A Workshop Series

Contact

Shalini Singaravelu

ssingaravelu@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Examining the Working Definition for Long COVID - Committee Meeting 5

October 25, 2023

10:00 AM - 1:00 PM (ET)

Past

About

The fifth meeting of the Committee on Examining the Working Definition for Long COVID will be held entirely in closed, committee-only, session.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

• Harvey Fineberg (Chair)
• Don Berwick
• Karyn Bishof
• Lily Chu
• Abigail Dumes
• Dennis Kolson
• Peter Palese
• Linda Sprague-Martinez
• Andrea Troxel
• Monica Verduzco-Gutierrez

The following topics were discussed in the closed sessions:

• Debrief from the symposium, discuss new evidence and issues, and discuss impact on approach for report and recommendations.
• Discuss the proposed working group work plan and approach.
• Discuss the overarching definition.
• Discuss key report topics.
• Review the timeline, identify information needs, outstanding issues for full committee consideration, future meeting plans and topics, and next steps.

The following materials (written documents) were made available to the committee in the closed sessions:

• Final Agenda
• Draft Long COVID Working Group Work Plan
• Report Development and Review Timeline

Date of posting of Closed Session Summary:

November 01, 2023

Organizing Project

Examining the Working Definition for Long COVID

Contact

LongCovid@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Closed

Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons Meeting #6

October 20, 2023

10:30 AM - 5:00 PM (ET)

Past

About

On October 20th, the Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons committee will hold its sixth meeting.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

Margaret Foster Riley, Ifeyinwa Asiodu, Paul Beninger, Alexander M. Capron, Brownsyne T. Edmonds, Ahizechukwu Eke, Mary Hebert, Leslie Meltzer Henry, Patricia A. King, Bruce Kuhlik, Anna C. Mastroianni, JoNell Efantis Potter, Enrique Schisterman

The following topics were discussed in the closed sessions:

Members of the Committee on Developing Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons held a meeting on October 20th. Committee members deliberated on the report recommendations and discussed the next steps and the study timeline.

The following materials (written documents) were made available to the committee in the closed sessions:

- Agenda
- Draft Report

Date of posting of Closed Session Summary:

October 25, 2023

Organizing Project

Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons

Contact

Study Staff

PRGLACstudy@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Small Group Discussions to Inform the Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment: A Workshop

October 17 - 19, 2023

Past

About

The National Academies of Science, Engineering, and Medicine (National Academies) is hosting a virtual workshop on November 6-7, 2023, on the Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment. To inform this work, the planning committee is planning several upcoming discussions to obtain feedback to ensure the workshop is aligned with the community’s needs and to ensure that the community’s experiences and perspectives are understood and considered.

Three online, topic-specific discussions are being held the week of October 16, 2023.

Public Health and Health Care Services Session (Tuesday, October 17, 6:00 p.m. – 7:00 p.m. ET) – Intended for those who specifically provide public health and health care services for the affected areas, such as public health practitioners, health care providers, and emergency medical services.
Pediatric Session (Wednesday, October 18, 6:00 p.m. – 7:00 p.m. ET) – Intended for those specifically concerned with the impact of the event on the pediatric population, such as school personnel and parents.
Mental Health Session (Thursday, October 19, 6:00 p.m. – 7:00 p.m. ET) – Intended for those who specifically provide mental and behavioral health care services for the affected areas.

For more information about the project, questions, or if you can’t attend the sessions, please reach out to Matthew Masiello, mmasiello@nas.edu.

Organizing Project

Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment: A Workshop

Contact

Matthew Masiello

(202) 334-2133
mmasiello@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Workshop 3: Public-Private Partnerships for Dispensing of Medical Countermeasures

October 17, 2023

12:00 PM - 2:00 PM (ET)

Past

Materials

About

About

Mass dispensing of medical countermeasures is a complex effort because of diverse public health emergencies (e.g., chemical, biological, radiological, or nuclear events) that can require very tight time constraints to deliver and administer significant volumes of medical countermeasures to the public. The focus of this workshop is on exploring how public-private partnerships can contribute to equitable access to and efficient dispensing and administration of medical countermeasures, with a particular focus on pharmacies and other non-traditional partners and points of access.

Specifically, this workshop will:

Share examples of how public-private partnerships can be coordinated to develop and implement medical countermeasure dispensing strategies and to ensure resources, including personnel, equipment, technology, and physical space, are in place to dispense medical countermeasures.
Share examples of how public-private partnerships can increase access to medical countermeasures through safe, familiar, and convenient locations.
Understand the barriers to and facilitators of public-private partnerships for access to and dispensing of medical countermeasures.
Identify how policies, systems, and perceptions need to shift to enable public-private partnerships for access to and dispensing of medical countermeasures.

Background

Many of the lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). Less focused on were those public-private partnerships that enabled the successful implementation (distribution, dispensing, monitoring, uptake, and utilization) of medical countermeasures (MCMs), also known as the “last-mile”.

A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a series of virtual public workshops to examine lessons learned and future opportunities for public-private partnerships through novel distribution and dispensing models to facilitate delivery, uptake. and utilization of medical countermeasures (MCM) to the public during a public health emergency. This workshop will be hosted by the Forum on Medical and Public Health Preparedness for Disasters and Emergencies.

The five-part workshop series will build on lessons learned from various public-private partnerships models deployed during the “last-mile” of the COVID-19 response and other recent health emergencies, such as retail pharmacies as points of diagnosis and dispensing of MCMs, and discuss potential paths forward for public-private partnerships to facilitate successful implementation of MCMs to the public during a health emergency. For this workshop series, MCMs are medicines and medical supplies that may be used to diagnose, prevent, or treat disease during a public health emergency.[1] Additionally, public-private partnerships refer to cross-sector collaborations between government, private for-profit, and non-profit entities.

Other workshops in the series include:

Workshop 1: Public-Private Partnerships for Data-Informed Decision-Making to Distribute, Dispense, and Administer Medical Countermeasures – Tuesday, October 3, 2023, 12:00 pm – 2:00 pm ET
Workshop 2: Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures – Thursday, October 12, 2023, 12:00 pm – 2:00 pm ET
Workshop 3: Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures – Tuesday, October 17, 2023, 12:00 pm – 2:00 pm ET
Workshop 4: Public-Private Partnerships for Distribution of Medical Countermeasures – Thursday, October 26, 2023, 12:00 pm – 2:00 pm ET
Workshop 5: Future Opportunities: Levers and Systems for Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures – Thursday, November 2, 2023, 12:00 pm – 2:00 pm ET

For additional information on the workshop series, please visit our project page.

Workshop Planning Committee

Ali S. Khan, M.D., M.P.H. (Chair), University of Nebraska Medical Center

Brooke Courtney, J.D., M.P.H., U.S. Food and Drug Administration

Nicole Errett, Ph.D., M.S.P.H., University of Washington

John Hick, M.D., Hennepin Healthcare

Christine Kosmos, M.S., Centers for Disease Control and Prevention

Nicolette Louissaint, Ph.D., Healthcare Distribution Alliance

Jennifer Martin, Pharm.D., Department of Veterans Affairs

Suzet McKinney, Dr.P.H., M.P.H., Sterling Bay

Anita Patel, Pharm.D., Walgreens

Sara Roszak, M.A., M.P.H., Dr.P.H., National Association of Chain Drug Stores

Monica Schoch-Spana, Ph.D., Johns Hopkins Center for Health Security

Stephen Thomas, Ph.D., University of Maryland

[1] CDC (U.S. Centers for Disease Control and Prevention). Medical Countermeasures. https://www.cdc.gov/orr/readiness/mcm2-508.html (Accessed September 5, 2023)

Organizing Project

Medical Countermeasures - Expanding Delivery and Increasing Uptake Through Public-Private Partnerships: A Workshop Series

Contact

Shalini Singaravelu

ssingaravelu@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Workshop 2: Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

October 12, 2023

12:00 PM - 2:00 PM (ET)

Past

Materials

About

Public acceptance and uptake of medical countermeasures can significantly impact the health and well-being of affected communities. The focus of this workshop is on exploring how public-private partnerships can enable the understanding, acceptance, and uptake of medical countermeasures, with a particular focus on at-risk and disproportionately affected populations.

Specifically, this workshop will:

Share examples of how public-private partnerships can be leveraged to enhance communication, community engagement, and demand strategies for acceptance and uptake medical countermeasures.
Understand the barriers to and facilitators of public-private partnerships for the acceptance and uptake or administration of medical countermeasures.
Identify how policies, systems, and perceptions need to shift to enable public-private partnerships for the acceptance and uptake of medical countermeasures.

Background

Many of the lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). Less focused on were those public-private partnerships that enabled the successful implementation (distribution, dispensing, monitoring, uptake, and utilization) of medical countermeasures (MCMs), also known as the “last-mile”.

A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a series of virtual public workshops to examine lessons learned and future opportunities for public-private partnerships through novel distribution and dispensing models to facilitate delivery, uptake. and utilization of medical countermeasures (MCM) to the public during a public health emergency. This workshop will be hosted by the Forum on Medical and Public Health Preparedness for Disasters and Emergencies.

The five-part workshop series will build on lessons learned from various public-private partnerships models deployed during the “last-mile” of the COVID-19 response and other recent health emergencies, such as retail pharmacies as points of diagnosis and dispensing of MCMs, and discuss potential paths forward for public-private partnerships to facilitate successful implementation of MCMs to the public during a health emergency. For this workshop series, MCMs are medicines and medical supplies that may be used to diagnose, prevent, or treat disease during a public health emergency.[1] Additionally, public-private partnerships refer to cross-sector collaborations between government, private for-profit, and non-profit entities.

Other workshops in the series include:

Workshop 1: Public-Private Partnerships for Data-Informed Decision-Making to Distribute, Dispense, and Administer Medical Countermeasures – Tuesday, October 3, 2023, 12:00 pm – 2:00 pm ET
Workshop 2: Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures – Thursday, October 12, 2023, 12:00 pm – 2:00 pm ET
Workshop 3: Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures – Tuesday, October 17, 2023, 12:00 pm – 2:00 pm ET
Workshop 4: Public-Private Partnerships for Distribution of Medical Countermeasures – Thursday, October 26, 2023, 12:00 pm – 2:00 pm ET
Workshop 5: Future Opportunities: Levers and Systems for Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures – Thursday, November 2, 2023, 12:00 pm – 2:00 pm ET

For additional information on the workshop series, please visit our project page.

Workshop Planning Committee

Ali S. Khan, M.D., M.P.H. (Chair), University of Nebraska Medical Center

Brooke Courtney, J.D., M.P.H., U.S. Food and Drug Administration

Nicole Errett, Ph.D., M.S.P.H., University of Washington

John Hick, M.D., Hennepin Healthcare

Christine Kosmos, M.S., Centers for Disease Control and Prevention

Nicolette Louissaint, Ph.D., Healthcare Distribution Alliance

Jennifer Martin, Pharm.D., Department of Veterans Affairs

Suzet McKinney, Dr.P.H., M.P.H., Sterling Bay

Anita Patel, Pharm.D., Walgreens

Sara Roszak, M.A., M.P.H., Dr.P.H., National Association of Chain Drug Stores

Monica Schoch-Spana, Ph.D., Johns Hopkins Center for Health Security

Stephen Thomas, Ph.D., University of Maryland

[1] CDC (U.S. Centers for Disease Control and Prevention). Medical Countermeasures. https://www.cdc.gov/orr/readiness/mcm2-508.html (Accessed September 5, 2023)

Organizing Project

Medical Countermeasures - Expanding Delivery and Increasing Uptake Through Public-Private Partnerships: A Workshop Series

Contact

Shalini Singaravelu

ssingaravelu@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Workshop 1: Public-Private Partnerships for Data-Informed Decision-Making to Distribute, Dispense, and Administer Medical Countermeasures

October 3, 2023

12:00 PM - 2:00 PM (ET)

Past

Discussion

This discussion information is being collected via Slido. Slido is not affiliated in any way with, or endorsed by, the National Academies of Sciences, Engineering, and Medicine, and your submission via the Slido website is subject to Slido’s privacy and terms of use.

Materials

About

The focus of this workshop is on exploring how public-private partnerships can bring timely and relevant information to decision makers to inform strategy and operations for medical countermeasure (MCM) distribution, dispensing, and administration.

Specifically, this workshop will:

Share examples of how public-private partnerships can be leveraged to enhance generation and use of timely and relevant data and information to inform strategy and operations.
Understand the barriers to and facilitators of public-private partnerships for data-informed decision-making to distribute, dispense, administer, and promote acceptance of MCMs.
Identify how policies, systems, and perceptions need to shift to enable public-private partnerships for data-informed decision-making to distribute, dispense, and administer MCMs.

Background

Many of the lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). Less focused on were those public-private partnerships that enabled the successful implementation (distribution, dispensing, monitoring, uptake, and utilization) of medical countermeasures (MCMs), also known as the “last-mile”.

A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a series of virtual public workshops to examine lessons learned and future opportunities for public-private partnerships through novel distribution and dispensing models to facilitate delivery, uptake. and utilization of medical countermeasures (MCM) to the public during a public health emergency. This workshop will be hosted by the Forum on Medical and Public Health Preparedness for Disasters and Emergencies.

The five-part workshop series will build on lessons learned from various public-private partnerships models deployed during the “last-mile” of the COVID-19 response and other recent health emergencies, such as retail pharmacies as points of diagnosis and dispensing of MCMs, and discuss potential paths forward for public-private partnerships to facilitate successful implementation of MCMs to the public during a health emergency. For this workshop series, MCMs are medicines and medical supplies that may be used to diagnose, prevent, or treat disease during a public health emergency.[1] Additionally, public-private partnerships refer to cross-sector collaborations between government, private for-profit, and non-profit entities.

Other workshops in the series include:

Workshop 1: Public-Private Partnerships for Data-Informed Decision-Making to Distribute, Dispense, and Administer Medical Countermeasures – Tuesday, October 3, 2023, 12:00 pm – 2:00 pm ET
Workshop 2: Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures – Thursday, October 12, 2023, 12:00 pm – 2:00 pm ET
Workshop 3: Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures – Tuesday, October 17, 2023, 12:00 pm – 2:00 pm ET
Workshop 4: Public-Private Partnerships for Distribution of Medical Countermeasures – Thursday, October 26, 2023, 12:00 pm – 2:00 pm ET
Workshop 5: Future Opportunities: Levers and Systems for Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures – Thursday, November 2, 2023, 12:00 pm – 2:00 pm ET

For additional information on the workshop series, please visit our project page.

Workshop Planning Committee

Ali S. Khan, M.D., M.P.H. (Chair), University of Nebraska Medical Center

Brooke Courtney, J.D., M.P.H., U.S. Food and Drug Administration

Nicole Errett, Ph.D., M.S.P.H., University of Washington

John Hick, M.D., Hennepin Healthcare

Christine Kosmos, M.S., Centers for Disease Control and Prevention

Nicolette Louissaint, Ph.D., Healthcare Distribution Alliance

Jennifer Martin, Pharm.D., Department of Veterans Affairs

Suzet McKinney, Dr.P.H., M.P.H., Sterling Bay

Anita Patel, Pharm.D., Walgreens

Sara Roszak, M.A., M.P.H., Dr.P.H., National Association of Chain Drug Stores

Monica Schoch-Spana, Ph.D., Johns Hopkins Center for Health Security

Stephen Thomas, Ph.D., University of Maryland

[1] CDC (U.S. Centers for Disease Control and Prevention). Medical Countermeasures. https://www.cdc.gov/orr/readiness/mcm2-508.html (Accessed September 5, 2023)

Organizing Project

Medical Countermeasures - Expanding Delivery and Increasing Uptake Through Public-Private Partnerships: A Workshop Series

Contact

Shalini Singaravelu

ssingaravelu@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Toward Sequencing and Mapping of RNA Modifications: Committee Meeting 11

October 2, 2023

2:00 PM - 4:00 PM (ET)

Past

About

This is the eleventh committee meeting of a consensus study tasked with conducting a study on direct sequencing of modifications of RNA (referred to as epitranscriptome) from humans and model organisms.

This meeting will be held over Zoom.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

Taekjip Ha, Markus Hafner, Nick Adams, Brenda Bass, Susan Baserga, Julius Beau Lucks, Keith Nykamp, Mary Majumder, Jeffrey Baker, Sarath Janga, Patrick Limbach, Kate Meyer

The following topics were discussed in the closed sessions:

During this closed session, committee members finalized big-picture conclusions and recommendations for consensus study report.

Date of posting of Closed Session Summary:

October 03, 2023

Organizing Project

Toward Sequencing and Mapping of RNA Modifications

Contact

Trisha Tucholski

(202) 334-3396
ttucholski@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life - Meeting #4

September 28 - 29, 2023

Past

About

This is the fourth meeting of the committee and will be hybrid with both in-person and virtual participants. The meeting will be closed and will not include a public session.

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

- Alan Leshner (chair)
- Suma Babu
- Chelsey R. Carter
- George Demiris
- John Dunlop
- Eva L. Feldman (Day 2 only)
- Holly Fernandez-Lynch
- Ileana Howard
- Jerome E. Kurent
- Won Young Lee
- Harold Paz
- Tonya Roberts
- Rita Sattler
- Joel Shamaskin
- Joshua M. Sharfstein
- Mindy Uhrlaub

The following topics were discussed in the closed sessions:

- August/September public workshops
- Draft findings, conclusions, and recommendations for the report

The following materials (written documents) were made available to the committee in the closed sessions:

- Agenda Book

Date of posting of Closed Session Summary:

October 10, 2023

Organizing Project

Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life

Contact

Rebecca English

(202) 334-2582
renglish@nas.edu

Location

National Academy of Sciences Building

2101 Constitution Ave NW

Washington DC 20418, USA

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons Committee Meeting #5

September 27 - 28, 2023

Past

Materials

About

On September 27 and 28th, the Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons committee held its fifth meeting.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

All members were present.

The following topics were discussed in the closed sessions:

Members of the Committee on Developing Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons held a meeting on September 27 and 28. On the first day in closed session, committee members deliberated on the report structure and individual chapters and ended the day discussing report recommendations. On the second day, committee members continued their discussion on recommendations in closed session and ended their meeting planning the next steps for the study and report.

The following materials (written documents) were made available to the committee in the closed sessions:

- Agenda
- Briefing Book

Organizing Project

Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons

Contact

Study Staff

PRGLACstudy@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

My Academies

Board on Health Sciences Policy

Community Listening Session to Inform the Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment: A Workshop

Workshop 4: Public-Private Partnerships for Distribution of Medical Countermeasures

Examining the Working Definition for Long COVID - Committee Meeting 5

Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons Meeting #6

Small Group Discussions to Inform the Public Health Research and Surveillance Priorities from the East Palestine, Ohio Train Derailment: A Workshop

Workshop 3: Public-Private Partnerships for Dispensing of Medical Countermeasures

Emerging Technologies and Innovation in Manufacturing Regenerative Medicine Therapies: A Workshop

Optimizing Public-Private Partnerships for Clinical Cancer Research: A Workshop

Preparing the Future Workforce in Drug Research and Development - A Workshop

Workshop 2: Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

Data Integration in Learning Health Care Systems for Traumatic Brain Injury: A Workshop

Workshop 1: Public-Private Partnerships for Data-Informed Decision-Making to Distribute, Dispense, and Administer Medical Countermeasures

Toward Sequencing and Mapping of RNA Modifications: Committee Meeting 11

Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life - Meeting #4

Developing a Framework to Address Legal, Ethical, Regulatory, and Policy Issues for Research Specific to Pregnant and Lactating Persons Committee Meeting #5